Loading clinical trials...
Loading clinical trials...
The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whole exome, or ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, Davis
NCT06934759 · Congenital Melanocytic Nevi, Congenital Melanocytic Nevus, and more
NCT07428941 · Skin Lesions, Melanocytic Nevi, and more
NCT01194947 · Common Melanocytic Nevi
University of California-Davis, Department of Dermatology
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions